Copeptin: a neuroendocrine biomarker of COVID-19 severity.
Biomark Med
; 16(8): 589-597, 2022 06.
Article
em En
| MEDLINE
| ID: mdl-35350852
We conducted a biochemical study on the role of copeptin a biomarker of acute stress due to COVID-19 infection in classification of COVID-19 severity on admission over 160 adult patients. Copeptin was highly elevated in severe cases more than the mild to moderate ones. So, it may be an early marker in admission departments to ease early clinical decisions and medical intervention.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
COVID-19
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article